Podnos Yale

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Podnos Yale's trades of Starling Oncology, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
34.74
Quantity 43,689
Value US$2,385,854
Transaction date
Planned sale
Price
5.38
Quantity 23,451 -8.3%
Value US$126,094
Transaction date
Proposed sale
Price
4.87
Quantity 23,451
Value US$114,206
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-16 2026-07-14
S Sale
96,843 -11.5%
420.42
US$4,879,964 		96,843 -11.5% 420.42 US$4,879,964
2026-07-16 2026-07-14
S Sale
80,235 +20.1%
38.64
US$416,126 		80,235 +20.1% 38.64 US$416,126
2026-07-14 2026-07-14
PrS Proposed sale
43,689
34.74
US$2,385,854 		43,689 34.74 US$2,385,854
2026-06-09 2026-06-08
PlS Planned sale
23,451 -8.3%
5.38
US$126,094 		23,451 -8.3% 5.38 US$126,094
2026-06-08 2026-06-08
PrS Proposed sale
23,451
4.87
US$114,206 		23,451 4.87 US$114,206
2025-03-28 2025-03-26
B Purchase
9,056 +12.9%
1.04
US$9,434 		9,056 +12.9% 1.04 US$9,434